HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Junichi Shimizu Selected Research
Junichi Shimizu Research Topics
Disease
32
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2023 - 11/2005
16
Neoplasms (Cancer)
11/2023 - 11/2005
8
Lung Neoplasms (Lung Cancer)
09/2023 - 06/2008
7
Neoplasm Metastasis (Metastasis)
04/2021 - 08/2005
6
Small Cell Lung Carcinoma (Small Cell Lung Cancer)
04/2022 - 10/2008
5
Adenocarcinoma of Lung
03/2021 - 10/2008
4
Adenocarcinoma
01/2017 - 10/2008
3
Pneumonia (Pneumonitis)
01/2022 - 11/2018
3
Interstitial Lung Diseases (Interstitial Lung Disease)
01/2022 - 11/2005
2
Disease Progression
11/2017 - 01/2007
2
Hepatocellular Carcinoma (Hepatoma)
12/2012 - 08/2005
2
Pain (Aches)
09/2011 - 03/2006
1
Death (Near-Death Experience)
09/2023
1
Brain Neoplasms (Brain Tumor)
05/2023
1
Head and Neck Neoplasms (Head and Neck Cancer)
08/2021
1
Stomach Neoplasms (Stomach Cancer)
08/2021
1
Pulmonary Embolism
08/2021
1
Colorectal Neoplasms (Colorectal Cancer)
08/2021
1
Liver Diseases (Liver Disease)
05/2021
1
Chemical and Drug Induced Liver Injury
05/2021
1
Vomiting
03/2021
1
Nausea
03/2021
1
Idiopathic Pulmonary Fibrosis
01/2020
1
Malignant Mesothelioma
11/2019
1
Stomatitis
10/2019
1
Breast Neoplasms (Breast Cancer)
10/2019
1
Paronychia
09/2018
1
Inflammation (Inflammations)
11/2017
1
Sarcoma (Soft Tissue Sarcoma)
01/2017
1
Necrosis
01/2015
1
Neuroendocrine Tumors (Neuroendocrine Tumor)
01/2015
1
Ascites
01/2015
1
Ulcer
09/2013
1
Hepatitis
12/2012
1
Febrile Neutropenia
09/2011
1
Chromosomal Instability (Chromosome Stability)
07/2010
Drug/Important Bio-Agent (IBA)
10
ErbB Receptors (EGF Receptor)
IBA
11/2023 - 01/2007
6
Nivolumab
IBA
08/2021 - 11/2017
6
Gefitinib (Iressa)
FDA Link
11/2017 - 11/2005
5
Anaplastic Lymphoma Kinase
IBA
11/2017 - 02/2014
4
Tyrosine Kinase Inhibitors
IBA
03/2021 - 01/2009
3
pembrolizumab
IBA
11/2022 - 11/2018
3
Immune Checkpoint Inhibitors
IBA
01/2022 - 01/2020
3
Monoclonal Antibodies
IBA
08/2021 - 11/2019
3
Carboplatin (JM8)
FDA Link
Generic
03/2021 - 06/2008
3
Crizotinib
IBA
10/2016 - 09/2013
2
Bevacizumab (Avastin)
FDA Link
08/2021 - 03/2021
2
osimertinib
IBA
03/2021 - 09/2018
2
Cisplatin (Platino)
FDA Link
Generic
01/2018 - 06/2008
2
Docetaxel (Taxotere)
FDA Link
11/2017 - 09/2011
2
Erlotinib Hydrochloride (CP 358,774)
FDA Link
11/2017 - 11/2009
2
Platinum
IBA
01/2017 - 12/2015
2
Messenger RNA (mRNA)
IBA
07/2010 - 06/2008
1
trastuzumab deruxtecan
IBA
11/2023
1
Nucleotides
IBA
11/2023
1
Elements
IBA
09/2023
1
lorlatinib
IBA
05/2023
1
B7-H1 Antigen
IBA
11/2022
1
Somatostatin Receptors (Somatostatin Receptor)
IBA
01/2022
1
Pemetrexed (MTA)
FDA Link
01/2022
1
dabrafenib
IBA
01/2022
1
trametinib
IBA
01/2022
1
fibrin fragment D (D-dimer)
IBA
08/2021
1
Fenbendazole
IBA
05/2021
1
Olanzapine (Zyprexa)
FDA Link
03/2021
1
Biomarkers (Surrogate Marker)
IBA
01/2020
1
Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)
IBA
11/2019
1
Glycoproteins (Glycoprotein)
IBA
11/2019
1
Everolimus
FDA Link
10/2019
1
Steroids
IBA
10/2019
1
TOR Serine-Threonine Kinases
IBA
10/2019
1
Antibodies
IBA
11/2018
1
S-1 plus cisplatin
IBA
01/2018
1
Vinorelbine (Navelbine)
FDA Link
Generic
01/2018
1
Afatinib
IBA
11/2017
1
alectinib
IBA
11/2017
1
ceritinib
IBA
11/2017
1
Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)
IBA
01/2017
1
Octreotide (Sandostatin)
FDA Link
Generic
01/2015
1
Tumor Biomarkers (Tumor Markers)
IBA
01/2015
1
Phosphopyruvate Hydratase (Enolase)
IBA
01/2015
1
Uracil
IBA
12/2012
1
Granulocyte Colony-Stimulating Factor (G-CSF)
IBA
12/2012
1
Sorafenib (BAY 43-9006)
FDA Link
12/2012
1
Tegafur
IBA
12/2012
1
Flavonoids
IBA
09/2011
1
vadimezan
IBA
09/2011
1
ran-binding protein 2
IBA
07/2010
1
Type II DNA Topoisomerases (Topoisomerase II)
IBA
07/2010
1
Protein Isoforms (Isoforms)
IBA
07/2010
1
Ubiquitin
IBA
07/2010
1
Ligases (Synthetase)
IBA
07/2010
Therapy/Procedure
16
Drug Therapy (Chemotherapy)
09/2023 - 11/2005
9
Therapeutics
11/2022 - 04/2010
5
Radiotherapy
06/2021 - 01/2007
5
Chemoradiotherapy
06/2021 - 01/2018
1
Terminal Care (Care, Terminal)
09/2023
1
Combination Drug Therapy (Combination Chemotherapy)
08/2021
1
Self Administration (Administration, Self)
05/2021
1
Segmental Mastectomy (Lumpectomy)
04/2021